Mozobil and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Mozobil (plerixafor), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Neupogen, and have Haematopoietic stem cell mobilisation.

The study is created by eHealthMe based on reports of 971 people who have side effects when taking Mozobil from the FDA, and is updated regularly.

What is Mozobil?

Mozobil has active ingredients of plerixafor. eHealthMe is studying from 972 Mozobil users. Check the latest studies of Mozobil.

On Jul, 20, 2026

971 people reported to have side effects when taking Mozobil.
Among them, 37 people (3.81%) died.

Among these 37 people:

How long have people been on Mozobil when they died? *

What is the gender of people who died when taking Mozobil? *

female: 59.09 %
male: 40.91 %

What is the age of people who died when taking Mozobil? *

What are other drugs people take besides Mozobil? *

What are other side effects people have before they died? *

Therapeutic Response Decreased (less preventive response): 4 people, 10.81%
Hypotension (abnormally low blood pressure): 4 people, 10.81%
Dehydration (dryness resulting from the removal of water): 3 people, 8.11%
The Flu (the flu is caused by an influenza virus): 3 people, 8.11%
Mucosal Inflammation (infection of mucous membrane): 3 people, 8.11%
Upper Respiratory Tract Infection: 3 people, 8.11%
Nausea (feeling of having an urge to vomit): 2 people, 5.41%
Cytomegalovirus Infection: 2 people, 5.41%
Cystitis Haemorrhagic (blood in the urine and painful voiding): 2 people, 5.41%
Bk Virus Infection: 2 people, 5.41%

What are the existing conditions these people have? *

Haematopoietic Stem Cell Mobilisation: 19 people, 51.35%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 18.92%
Multiple Myeloma (cancer of the plasma cells): 7 people, 18.92%
Upper Respiratory Tract Infection: 4 people, 10.81%
Diarrhea: 3 people, 8.11%
Depression: 3 people, 8.11%
Nausea (feeling of having an urge to vomit): 3 people, 8.11%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 8.11%
High Blood Pressure: 2 people, 5.41%
Cough: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mozobil:

Mozobil (972 reports)

Expand to all the drugs that have ingredients of plerixafor:

Death and drugs with ingredients of plerixafor (66 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mozobil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,125 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on plerixafor (the active ingredients of Mozobil) and Mozobil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.